| Literature DB >> 26136578 |
Mona C Gjessing1, Natalya Yutin2, Torstein Tengs3, Tania Senkevich4, Eugene Koonin2, Hans Petter Rønning5, Marta Alarcon3, Sonja Ylving3, Kai-Inge Lie3, Britt Saure3, Linh Tran3, Bernard Moss6, Ole Bendik Dale3.
Abstract
UNLABELLED: Poxviruses are large DNA viruses of vertebrates and insects causing disease in many animal species, including reptiles, birds, and mammals. Although poxvirus-like particles were detected in diseased farmed koi carp, ayu, and Atlantic salmon, their genetic relationships to poxviruses were not established. Here, we provide the first genome sequence of a fish poxvirus, which was isolated from farmed Atlantic salmon. In the present study, we used quantitative PCR and immunohistochemistry to determine aspects of salmon gill poxvirus disease, which are described here. The gill was the main target organ where immature and mature poxvirus particles were detected. The particles were detected in detaching, apoptotic respiratory epithelial cells preceding clinical disease in the form of lethargy, respiratory distress, and mortality. In moribund salmon, blocking of gas exchange would likely be caused by the adherence of respiratory lamellae and epithelial proliferation obstructing respiratory surfaces. The virus was not found in healthy salmon or in control fish with gill disease without apoptotic cells, although transmission remains to be demonstrated. PCR of archival tissue confirmed virus infection in 14 cases with gill apoptosis in Norway starting from 1995. Phylogenomic analyses showed that the fish poxvirus is the deepest available branch of chordopoxviruses. The virus genome encompasses most key chordopoxvirus genes that are required for genome replication and expression, although the gene order is substantially different from that in other chordopoxviruses. Nevertheless, many highly conserved chordopoxvirus genes involved in viral membrane biogenesis or virus-host interactions are missing. Instead, the salmon poxvirus carries numerous genes encoding unknown proteins, many of which have low sequence complexity and contain simple repeats suggestive of intrinsic disorder or distinct protein structures. IMPORTANCE: Aquaculture is an increasingly important global source of high-quality food. To sustain the growth in aquaculture, disease control in fish farming is essential. Moreover, the spread of disease from farmed fish to wildlife is a concern. Serious poxviral diseases are emerging in aquaculture, but very little is known about the viruses and the diseases that they cause. There is a possibility that viruses with enhanced virulence may spread to new species, as has occurred with the myxoma poxvirus in rabbits. Provision of the first fish poxvirus genome sequence and specific diagnostics for the salmon gill poxvirus in Atlantic salmon may help curb this disease and provide comparative knowledge. Furthermore, because salmon gill poxvirus represents the deepest branch of chordopoxvirus so far discovered, the genome analysis provided substantial insight into the evolution of different functional modules in this important group of viruses.Entities:
Mesh:
Year: 2015 PMID: 26136578 PMCID: PMC4542343 DOI: 10.1128/JVI.01174-15
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103
Overview of material from Norwegian salmon farms
| Fish | No. of fish with gill apoptosis | No. of fish/no. of farms | ||||
|---|---|---|---|---|---|---|
| Archival cases, 1995–2006 | Controls (no gill apoptosis) | |||||
| Farm A | Farm B | Farm C | Diseased fish | Healthy fish | ||
| Archival cases and controls | 39/14 | 48/8 | 3/1 | |||
| Diseased fish | ||||||
| Premortality | 20 | |||||
| Mortality | 30 | 25 | 5 | |||
| Postmortality | 10 | |||||
Sampling was performed on 5 dead and 25 moribund fish. Except for the 5 dead fish, all fish used in this study were sampled while still alive.
Overview of gill lesions in the controls (no gill apoptosis)
| Farm | No. of fish | Gill histopathology and agents visible on light microscopy |
|---|---|---|
| D | 9 | Moderate adherences of lamellae and parasitic flagellates ( |
| E | 4 | Moderate detachment of lamellar epithelial cells |
| F | 4 | Moderately thickened lamellae due to epithelial hypertrophy |
| G | 4 | Severe epithelial proliferation |
| H | 4 | Moderate lifting of epithelial cells and fungal infection |
| I | 3 | Moderate epithelial hypertrophy |
| J | 4 | Severe epithelial proliferation |
| K | 10 | Focal detachment and necrosis of lamellar epithelial cells and bacteria colonizing the apical surface of epithelium |
| L | 6 | Moderate hypertrophy and necrosis of epithelial cells; mucous cell proliferation |
Overview of results
| Clinical stage | No. of fish | Median (range) | % of fish with: | |
|---|---|---|---|---|
| IHC of gills | Hemophagocytosis | |||
| Premortality | 220 | 18.1 (15.8–22.4) | 95 | 0 |
| Mortality | 660 | 20.5 (15.7–28.9) | 91.4 | 66.7 |
| Postmortality | 110 | 24.7 (18.9–30.7) | 20 | 20 |
Two dead fish were not suited for IHC because of autolysis.
FIG 1Normal tissues and pathology in SGPV-infected Atlantic salmon. (a) A normal gill with thin lamellae (arrows) ensures efficient gas exchange. Chloride cells are present in normal numbers and at the normal location (arrowheads). (b and c) Detaching apoptotic cells with central clearing of chromatin (arrows) in the nuclear seen by H&E staining (b) and confirmed by red TUNEL staining (c). (d and e) IHC staining of poxvirus (brown) as cytoplasmic granules (d) and apical budding processes from apoptotic gill epithelial cells (e). (f) H&E staining of collapsed, adherent (arrows) thin lamellae losing apoptotic epithelial cells, creating an atelectasis-like condition hindering gas exchange. (g) H&E staining of proliferating (the arrow indicates metaphase), pale, foamy epithelial cells occluding the normally water-filled interlamellar space for gas exchange. Chloride cells are displaced and degenerated (arrowhead). (h) The lesion in panel g stained by IHC for PCNA showing brown nuclei, including proliferating cells in metaphase (arrow). (i and j) The lesion in panel g stained by IHC for chloride cells (red) that are displaced and enlarged (i) compared to the chloride cells in a normal gill (j). (k) TEM showing virus particles consistent with poxvirus in size and shape. Note the presence of crescents (CR), immature virions (IVs), and mature virions (MVs). (l) H&E staining of prominent hemophagocytosis (arrows) in the hematopoietic interrenal tissue. Methods included H&E staining (a, b, f, g, l); IHC staining for TUNEL (c), salmon gill poxvirus (d, e), PCNA (h), and chloride cells (i, j); and TEM (k).
Predicted genes of SGPV
| SGPV gene | Genome coordinates (protein length | NCVOG no. | Representation among NCLDVs | VACV gene name | Best hit (GI|Eval|% identity|aln_len|organism) | Predicted TM and SP | Functional annotation, comments, or inferred origin |
|---|---|---|---|---|---|---|---|
| 001 | 1248–298 (317) | Hypothetical protein | |||||
| 002 | 2205–1288 (306) | Hypothetical protein | |||||
| 003 | 3227–2241 (329) | Hypothetical protein; low sequence complexity | |||||
| 004 | 4788–3361 (476) | Hypothetical protein | |||||
| 005 | 5884–4934 (317) | Hypothetical protein | |||||
| 006 | 7314–6361 (318) | Hypothetical protein | |||||
| 007 | 7770–7438 (111) | Hypothetical protein | |||||
| 008 | 8702–7830 (291) | Hypothetical protein | |||||
| 009 | 9383–9054 (110) | 1 TM (C) | Hypothetical type I membrane protein, heptad repeats | ||||
| 010 | 9911–9546 (122) | Hypothetical protein; low sequence complexity | |||||
| 011 | 11295–10021 (425) | Hypothetical protein; low sequence complexity | |||||
| 012 | 12365–11373 (331) | Hypothetical protein | |||||
| 013 | 13629–12421 (403) | Hypothetical protein | |||||
| 014 | 15099–13681 (473) | Hypothetical protein | |||||
| 015 | 15912–15166 (249) | Hypothetical protein | |||||
| 016 | 16318–16007 (104) | Hypothetical protein | |||||
| 017 | 17728–16409 (440) | Hypothetical protein | |||||
| 018 | 18401–17922 (160) | Hypothetical protein | |||||
| 019 | 18870–18373 (166) | Hypothetical protein | |||||
| 020 | 19147–18863 (95) | Hypothetical protein | |||||
| 021 | 19468–19196 (91) | Hypothetical protein | |||||
| 022 | 19721–19533 (63) | 1 TM (M) | Hypothetical membrane protein | ||||
| 023 | 20272–19751 (174) | Hypothetical protein | |||||
| 024 | 21336–20332 (335) | Hypothetical protein | |||||
| 025 | 21953–21345 (203) | Hypothetical protein | |||||
| 026 | 23067–21967 (367) | Hypothetical protein | |||||
| 027 | 24336–23167 (390) | Hypothetical protein | |||||
| 028 | 25255–24395 (287) | Hypothetical protein | |||||
| 029 | 25986–25294 (231) | Hypothetical protein | |||||
| 030 | 26353–26033 (107) | Hypothetical protein | |||||
| 031 | 26850–26389 (154) | 1 TM (C) | Hypothetical type I membrane protein | ||||
| 032 | 27837–26851 (329) | 0017 | Phy, Mimi, Ent | 401825817|3.E−11|28|180| | |||
| 033 | 28446–27847 (200) | Hypothetical protein | |||||
| 034 | 28512–30752 (747) | 0330 | Most NCLDVs, all families except Asf | 660515722|3.E-07|26|242| | Divergent RING finger protein, potential E3 subunit of ubiquitin ligase; uncharacterized N-terminal domain upstream of RING domain; RING proteins in different NCLDVs likely have different origins; this SGPV protein is most similar to homologs from Iri and Phy; CACQ | ||
| 035 | 31420–30749 (224) | Hypothetical protein | |||||
| 036 | 32306–31434 (291) | Hypothetical protein | |||||
| 037 | 34172–32325 (616) | Hypothetical protein | |||||
| 038 | 34466–34263 (68) | SP | Hypothetical protein | ||||
| 039 | 34829–34503 (109) | Hypothetical protein | |||||
| 040 | 35364–34792 (191) | 0202 | Pox, Iri | 617520525|5.E-06|30|123| | 1 TM (C), SP | Ig domain type I membrane protein; not closely related to Ig domain-containing proteins of other NCLDVs; CACQ | |
| 041 | 35957–35583 (125) | Hypothetical protein | |||||
| 042 | 36110–36592 (161) | 1 TM | Hypothetical protein | ||||
| 043 | 36828–37679 (284) | 0284 | Some representatives of most NCLDVs except Asf | 511086842|1.E-59|39|276| | Ser/Thr protein kinase; probable eukaryotic origin; putative ribosomal protein S6K, mTOR pathway component; not closely related to any other NCLDV kinase, likely independent origin; CACQ | ||
| 044 | 38096–37665 (144) | 1 TM (M) | Hypothetical membrane protein | ||||
| 045 | 39115–38135 (327) | 1068 | Scattered distribution in all NCLDV families | F2L | 254568556|8.E-14|33|141| | 1 TM (N) | Trimeric dUTPase highly similar to homologs from Phy but not poxviruses; contains uncharacterized N-terminal domain with a predicted TM; ANC |
| 046 | 39674–39102 (191 | Hypothetical protein | |||||
| 047 | 40162–39689 (158) | Hypothetical protein | |||||
| 048 | 40352–40882 (177) | Hypothetical protein | |||||
| 049 | 41988–40891 (366) | Hypothetical protein | |||||
| 050 | 42947–42033 (305) | Hypothetical protein | |||||
| 051 | 45667–42950 (906) | 502875360|8.E-4|24|403| | Metalloendopeptidase of the M60-like family; UAQ | ||||
| 052 | 46422–45664 (253) | 1 TM (C) | Hypothetical type I membrane protein | ||||
| 053 | 46580–46422 (53) | 1 TM (C) | Hypothetical type I membrane protein | ||||
| 054 | 47190–46636 (185) | 1 TM (N) | Hypothetical type II membrane protein | ||||
| 055 | 48431–47325 (369) | Hypothetical protein | |||||
| 056 | 49116–48292 (275) | Hypothetical protein | |||||
| 057 | 50255–49101 (385) | Hypothetical protein | |||||
| 058 | 52022–50265 (586) | Hypothetical protein | |||||
| 059 | 52040–52516 (159) | 1122 | All Pox, some Iri, Mimi | J5 | 1 TM | Myristylated membrane protein, entry-fusion complex subunit; ANC; TAAATG | |
| 060 | 53257–52439 (273) | Hypothetical protein | |||||
| 061 | 53859–53299 (187) | 0258 | All Chor | J4R | 13876678|1E−08|31|186|lumpy skin disease virus | DNA-dependent RNA polymerase subunit Rpo22; CPOX | |
| 062 | 54821–53886 (312) | 1152 | All Pox, Pith, some Mimi | J3R | 41057489|3E−42|36|276|bovine papular stomatitis virus | Poly(A) polymerase small subunit, cap | |
| 063 | 55426–54788 (213) | Hypothetical protein | |||||
| 064 | 55824–55390 (145) | 1 TM (M) | Hypothetical membrane protein | ||||
| 065 | 56600–55842 (253) | 1063 | All Pox | L4R | DNA-binding virion core protein VP8; POX; TAAATG | ||
| 066 | 56631–57599 (323) | 1168 | All Pox | L3L | 659488262|5.E-08|24|308|penguinpox virus | Virion protein required for early transcription; POX | |
| 067 | 59023–57596 (476) | 0295 | Most NCLDV families except Asf and Pan | F10L | 544837|6.E-26|28|396|variola virus VAR, India-1967, peptide, 439 amino acids | Protein kinase involved in early stages of virion morphogenesis; ANC | |
| 068 | 59043–59897 (285) | 0249 | All NCLDVs | A32L | 12085104|1.E-17|28|264|Yaba-like disease virus | DNA packaging ATPase; ANC; TAAATG | |
| 069 | 59901–60317 (139) | Hypothetical protein | |||||
| 070 | 62029–60323 (569) | 1165 | All Pox | E1L | 9631476|2.E-14|23|381| | Poxvirus poly(A) polymerase catalytic subunit POX | |
| 071 | 62691–62071 (207) | 0272 | All Pox, most other NCLDVs | E4L | 38229198|5.E-18|29|174|Yaba monkey tumor virus | Transcription factor S-II (TFIIS); ANC; TAAATG | |
| 072 | 63448–62681 (256) | Hypothetical protein | |||||
| 073 | 64802–63516 (429) | Hypothetical protein | |||||
| 074 | 64862–66538 (559) | 1173 | All Pox | E6R | 40556061|3E-07|19|547|canarypox virus | Virion protein required for the formation of mature virions; POX; TAAATG | |
| 075 | 66539–67645 (369) | Hypothetical protein; low sequence complexity | |||||
| 076 | 70831–67634 (1,066) | 0038 | All NCLDVs | E9L | 659488229|5E−142|32|1027|penguinpox virus | DNA polymerase ANC | |
| 077 | 71147–70848 (100) | 0052 | All NLCDVs | E10R | 40556058|3E−24|48|92|canarypox virus | 1 TM (false positive) | Disulfide (thiol) oxidoreductase (Erv1/Alr family) involved in disulfide bond formation during virion morphogenesis; ANC; TAAATG |
| 078 | 71159–71788 (210) | Hypothetical protein | |||||
| 079 | 72152–71760 (131) | Hypothetical protein | |||||
| 080 | 73310–72168 (381) | 1160 | All Chor | I1L | 5830616|4E−13|27|281|variola minor virus | DNA-binding virion core protein; CPOX | |
| 081 | 74930–73677 (418) | Hypothetical protein | |||||
| 082 | 76048–74933 (372) | 1171 | All Chor | I6L | Telomere-binding protein involved in viral DNA encapsidation; CPOX; TAAATG | ||
| 083 | 77179–76049 (377) | Hypothetical protein | |||||
| 084 | 77295–78926 (544) | Hypothetical protein | |||||
| 085 | 79246–78857 (130) | Hypothetical protein; low sequence complexity | |||||
| 086 | 81234–79657 (526) | Hypothetical protein; low sequence complexity | |||||
| 087 | 81913–81221 (231) | Hypothetical protein; low sequence complexity | |||||
| 088 | 81912–82319 (136) | 4 TM | Protein consists of hydrophobic decamer repeats; TM prediction could be spurious | ||||
| 089 | 86171–82275 (1,299) | 0190 | Hypothetical protein | ||||
| 090 | 88408–86198 (737) | 0031 | Nearly all NCLDVs | D6R | 345107280|1E−156|41|657|Yoka poxvirus | SNF2-like helicase involved in early transcription; ANC | |
| 091 | 90927–88453 (825) | 0023 | All NCLDVs | D5R | 571798002|5E−93|28|768|squirrelpox virus | Primase-helicase; ANC | |
| 092 | 91684–90920 (255) | 0211 | All Chor | F9L | 9634782|8E−06|33|123|fowlpox virus | 1 TM (C) | Myristylated IMV envelope protein; CPOX; TAAATG |
| 093 | 92207–91647 (187) | Hypothetical protein | |||||
| 094 | 92262–92876 (205) | 1067 | Mimi | 494264790|3E−09|28|178| | Deoxynucleotide monophosphate kinase shared with Mimi, probable bacterial origin; CACQ | ||
| 095 | 96496–93050 (1,149) | 0037 | Phy, Mimi, Mar, CrPV (multiple paralogs) but not other Pox | 5121|2E−53|25|933| | DNA topoisomerase II; ANC | ||
| 096 | 96825–96496 (110) | 1 TM (M) | Hypothetical membrane protein | ||||
| 097 | 97628–96828 (267) | 0211 | Most NCLDVs, all Pox | L1R | 12085043|2E−29|31|225|Yaba-like disease virus | 1 TM (C) | Myristylated IMV envelope protein; ANC; TAAATG |
| 098 | 99427–97661 (589) | 0022 | All NCLDVs except Pan | D13L | 345107288|8E−50|28|570|Yoka poxvirus | Major capsid protein (involved in morphogenesis but not incorporated into virions in poxviruses); ANC | |
| 099 | 99845–99456 (130) | 1164 | All NCLDV | A1L | 289183841|1E−12|29|123|pseudocowpox virus | Late transcription factor VLTF-2; ANC | |
| 100 | 100665–99853 (271) | 0262 | All NCLDVs except Pith | A2L | 571798015|7E−8|38|195|squirrelpox virus | Late transcription factor VLTF; ANC | |
| 101 | 103192–100967 (742) | 1162 | All Pox, Mimi | A3L | 115531788|1E−49|24|697|Nile crocodilepox virus | Poxvirus P4B major core protein; POX | |
| 102 | 103950–103237 (238) | MCV, some Mimi, Phy | J domain-containing protein, putative cochaperonin; distantly related to J domains of other NCLDVs; CACQ | ||||
| 103 | 103956–104498 (181) | 1377 | All Chor | A5R | 40556180|3E−14|33|172|canarypox virus | DNA-dependent RNA polymerase subunit Rpo19; CPOX | |
| 104 | 105738–104503 (412) | 1179 | All Chor | A6L | Virion core protein required for membrane biogenesis and formation of mature virions; CPOX; TAAATG | ||
| 105 | 107964–105751 (738) | 0261 | All Pox, scattered in other NCLDVs | A7L | 659488305|2E−104|32|734|penguinpox virus | VETF, large subunit; ANC | |
| 106 | 107945–109252 (436) | 1176 | All Chor | A8R | 40556183|2E−08|24|248|canarypox virus | Poxvirus intermediate transcription factor VITF-3 subunit; CPOX; TAAATG | |
| 107 | 109518–109261 (86) | 2 TM | Hypothetical membrane protein | ||||
| 108 | 113053–109535 (1,173) | 0257 | All Pox | A10L | 157939724|4E−13|20|561|tanapox virus | Virion core protein P4; POX; TAAATG | |
| 109 | 113084–113923 (280) | Hypothetical protein | |||||
| 110 | 113964–114296 (111) | 1 TM (N) | Hypothetical type II membrane protein | ||||
| 111 | 114326–114619 (98) | Hypothetical protein; low sequence complexity | |||||
| 112 | 114935–114600 (112) | Hypothetical protein containing serine-rich repeats | |||||
| 113 | 115188–115556 (123) | Hypothetical protein | |||||
| 114 | 115768–115556 (71) | 1 TM (N) | Hypothetical type II membrane protein | ||||
| 115 | 117013–115769 (415) | 1045 | Some Iri and Mimi | 339906034|2E−07|30|145|Wiseana iridescent virus | 5′-3′ exoribonuclease of the XRN family; NCLDV proteins appear to be monophyletic; ANC | ||
| 116 | 117383–117045 (113) | 2 TM | Hypothetical protein | ||||
| 117 | 117721–117401 (107) | Hypothetical protein | |||||
| 118 | 118830–117736 (365) | 1122 | All Pox, Mimi, some Iri | A16L | 41057529|2E−15|29|204|bovine papular stomatitis virus | 1 TM | Myristylated protein, entry-fusion complex subunit; ANC; TAAATG |
| 119 | 119936–118848 (363) | 2 TM | Hypothetical membrane protein | ||||
| 120 | 119988–121418 (477) | 0076 | All Pox, in many other NCLDVs | A18R | 115531805|1E−54|29|424|Nile crocodilepox virus | DNA helicase of superfamily 2, transcript release factor; ANC | |
| 121 | 121419–122474 (352) | 2643 | Some Mimi | 504603808|3E−15|30|151| | Apurinic-apyrimidinic endonuclease of the exonuclease III family; probable bacterial origin; CACQ | ||
| 122 | 122812–122465 (116) | 1370 | All Pox | A21L | 506498863|2E−06|24|111| | 1 TM (C) | Type I membrane protein, entry-fusion complex subunit; POX; TAAATG |
| 123 | 122842–125133 (764) | 0035 | CrPV, Ent, some Iri, Mimi | NAD+-dependent DNA ligase; poorly conserved sequence but contains intact catalytic residues and shows the closest sequence similarity to NAD+-dependent ligases of Ent; ANC | |||
| 124 | 125105–125602 (166) | 0278 | All Pox, majority of other NCLDVs | A22R | 659488557|6E−16|32|149|pigeonpox virus | RuvC family Holliday junction resolvase; ANC | |
| 125 | 125599–126816 (406) | 0263 | All Pox | A23R | 9634858|3E−25|27|395|fowlpox virus | Intermediate transcription factor; POX | |
| 126 | 126817–130305 (1,163) | 0271 | All NCLDVs except some Phy | A24R | 225194776|0|47|1169|skunkpox virus | DNA-directed RNA polymerase subunit beta; TAAATG | |
| 127 | 130720–130310 (137) | 1418 | All Pox | A28L | 51317191|3E−17|33|128| | 1 TM (N) | Type I membrane protein, entry-fusion complex subunit beta; ANC; TAAATG |
| 128 | 131699–130725 (325) | 0260 | All Pox | A29L | 148912996|9E−08|27 |181|goatpox virus Pellor | DNA-directed RNA polymerase, 35-kDa subunit; POX | |
| 129 | 131870–132817 (316) | Hypothetical protein | |||||
| 130 | 132821–133525 (235) | Hypothetical protein | |||||
| 131 | 133536–135035 (500) | Hypothetical protein | |||||
| 132 | 135013–135495 (161) | Hypothetical protein | |||||
| 133 | 135919–135470 (150) | Hypothetical protein | |||||
| 134 | 136606–135941 (222) | 1115 | All Pox, scattered in other NCLDVs | D4R | 9634732|1E−15|28|216|fowlpox virus | UDG; ANC | |
| 135 | 136671–138380 (570) | Hypothetical protein; low sequence complexity | |||||
| 136 | 138373–139212 (280) | 0259 | All Pox | D7R | 9629029|4E−17|30|145|molluscum contagiosum virus subtype 1 | DNA-directed RNA polymerase, 18-kDa subunit; POX | |
| 137 | 139235–139879 (215) | 0236 | All Pox, most other NCLDVs | D10R | 9629031|1E−15|29 |161|molluscum contagiosum virus subtype 1 | Nudix hydrolase, decapping enzyme; ANC | |
| 138 | 141785–139887 (633) | 0027 | All Pox, some Mimi | D11L | 115531782|2E−174|43|635|Nile crocodilepox virus | Superfamily 2 helicase D11; POX; TAAATG | |
| 139 | 141949–142902 (318) | 0330 | All NCLDVs except Asco and Pith | 658035022|2E−06|31|75| | RING finger-containing E3 ubiquitin ligase; probably independent acquisition in different NCLDV families; CACQ | ||
| 140 | 143889–142951 (313) | 1169 | All Pox | D12L | 9629033|3E−31|30|289|molluscum contagiosum virus subtype 1 | Poxvirus mRNA capping enzyme, small subunit; POX; TAAATG | |
| 141 | 144893–143889 (335) | 1122 | All Pox, some Mimi, Iri | G9R | 9634797|7E−06|36|78|fowlpox virus | 1 TM | Myristylated protein, entry-fusion complex subunit; ANC; TAAATG |
| 142 | 145769–144894 (292) | 1369 | All Chor | G8R | 41057481|1E−06|26|171|bovine papular stomatitis virus | Protein containing a derived PCNA domain; VLTF-1; CPOX; TAAATG | |
| 143 | 145819–147291 (491) | Hypothetical protein | |||||
| 144 | 147884–147288 (199) | 1182 | All Pox | G6R | Predicted hydrolase or acyltransferase of the NlpC/P60 superfamily; weak sequence similarity to orthologs in other poxviruses; POX; TAAATG | ||
| 145 | 148111–147914 (66) | 1368 | All Chor, one Ent, Asf | G5.5R | 289183806|2E−04|24|65|pseudocowpox virus | RNA polymerase, subunit 10 (a very small protein, possibly missed during genome annotation of other viruses); POX | |
| 146 | 149892–148072 (607) | 1060 | All Pox, scattered in other NCLDVs | G5R | 539191060|6E−13|36|176|myxoma virus | Flap endonuclease required for poxvirus genome replication; ANC | |
| 147 | 149931–150485 (185) | 505137967|1E−05|41|59| | Thioredoxin; no close homologs in other viruses; UAQ | ||||
| 148 | 150507–150884 (126) | 1 TM (M) | Hypothetical membrane protein | ||||
| 149 | 150881–152773 (631) | 1170 | All Pox | G1L | 115531736|6E−35|31|233|Nile crocodilepox virus | Metalloprotease essential for virion morphogenesis; POX; TAAATG | |
| 150 | 154796–152760 (679) | 0267 | All Pox, Asf, Mimi | I8R | 41057099|5E−121|37|597|orf virus | RNA helicase of superfamily 2 implicated in early transcription termination; ANC; TAAATG | |
| 151 | 154823–156076 (418) | 1161 | All Pox, most other NCLDVs | I7L | 115531734|7E−15|21|429| | Virion core cysteine protease involved in virion protein maturation; ANC; TAAATG | |
| 152 | 156073–156567 (165) | Hypothetical protein | |||||
| 153 | 156623–157354 (244) | 1 TM (C), SP | Hypothetical protein | ||||
| 154 | 157464–164144 (2,227) | 0269 | All Chor; disrupted in some, including VACVs | (B22R VARV) | 422933904|3E−120|29|1049|cyprinid herpesvirus 2 | 1 TM (C), SP | Giant type I membrane protein with homologs also in cyprinid herpesviruses, suggestive of gene transfer from SGPV to the herpesviruses (see the phylogenetic tree in |
| 155 | 164257–168030 (1,258) | 1 TM (C), SP | Hypothetical type I membrane protein | ||||
| 156 | 168031–169008 (326) | Hypothetical protein | |||||
| 157 | 168995–169900 (302) | Hypothetical protein | |||||
| 158 | 170583–169939 (215) | Hypothetical protein | |||||
| 159 | 170638–173652 (1,005) | 0269 | All Chor; disrupted in some, including VACV | 0 | 9634792|5E−11|24|462|fowlpox virus | 1 TM (C), SP | Giant type I membrane protein with homologs also in cyprinid herpesviruses, suggestive of gene transfer from SGPV to the herpesviruses (see the phylogenetic tree in |
| 160 | 173910–173665 (82) | 1 TM (N) | Hypothetical type II membrane protein containing pentapeptide repeats | ||||
| 161 | 173870–181351 (2,494) | SP | Hypothetical secreted protein | ||||
| 162 | 181528–185433 (1,302) | 0269 | All Chor; disrupted in some, including VACVs | 0 | 9628967|5E−25|25|413|molluscum contagiosum virus subtype 1 | 1 TM (C), SP | Giant type I membrane protein with homologs also in cyprinid herpesviruses, suggestive of gene transfer from SGPV to the herpesviruses (see the phylogenetic tree in |
| 163 | 185473–186558 (362) | Hypothetical protein | |||||
| 164 | 186693–188648 (652) | SP | Hypothetical secreted protein | ||||
| 165 | 188749–192687 (1,313) | 0274 | All NCLDVs except for some Phy | J6R | 115531763|0|41|1311|Nile crocodilepox virus | DNA-directed RNA polymerase subunit alpha; ANC | |
| 166 | 193271–192684 (196) | 1 TM (C) | Hypothetical type I membrane protein | ||||
| 167 | 193287–194597 (437) | SP | Hypothetical secreted protein, pentapeptide repeats | ||||
| 168 | 195155–194586 (190) | 0253 | All Pox | H2R | 594019595|2E−35|40|151|avipoxvirus OKr-2014 | 1 TM (N) | Type II membrane protein, fusion-entry complex subunit; POX; TAAATG |
| 169 | 197626–195161 (822) | 1163 | All Pox | H4L | 6969751|3E−67|30|583|vaccinia virus Tian Tan | Pox_Rap94, RNA polymerase-associated transcription specificity factor, Rap94; POX; TAAATG | |
| 170 | 197724–198404 (227) | Hypothetical protein | |||||
| 171 | 198405–199343 (313) | 0036 | All Pox, Mimi | H6R | 345107272|5E−60|40|310|Yoka poxvirus | DNA topoisomerase IB; ANC; TAAATG | |
| 172 | 199715–199329 (129) | SP | Hypothetical secreted protein | ||||
| 173 | 199747–202368 (874) | 1451 | All NCDLVs except Asco and Pan | D1R | 225194732|4E−110|33|867|volepox virus | mRNA capping enzyme large subunit; ANC; TAAATG | |
| 174 | 204943–202382 (854) | Hypothetical protein | |||||
| 175 | 205237–204956 (94) | Hypothetical protein | |||||
| 176 | 205654–205238 (139) | Hypothetical protein | |||||
| 177 | 205659–207647 (663) | Hypothetical protein | |||||
| 178 | 207690–209033 (448) | Hypothetical protein | |||||
| 179 | 209178–209951 (258) | Hypothetical protein | |||||
| 180 | 210027–211280 (418) | Hypothetical protein | |||||
| 181 | 211532–213193 (554) | Hypothetical protein | |||||
| 182 | 213211–213954 (248) | Hypothetical protein | |||||
| 183 | 213947–214258 (104) | Hypothetical protein | |||||
| 184 | 214236–214847 (204) | Hypothetical protein | |||||
| 185 | 215300–214851 (150) | Hypothetical protein | |||||
| 186 | 215396–216664 (423) | 167525479|6E−18|28|228| | DNA or RNA methyltransferase; UAQ | ||||
| 187 | 216775–217242 (156) | 209734208|9E−29|46|127| | Macrodomain, most similar to | ||||
| 188 | 217294–218286 (331) | Hypothetical protein | |||||
| 189 | 218360–219514 (385) | Hypothetical protein | |||||
| 190 | 219572–220492 (307) | Hypothetical protein; low sequence complexity; partly consists of tetrapeptide repeats | |||||
| 191 | 220576–221535 (320) | Hypothetical protein | |||||
| 192 | 221579–222580 (334) | Hypothetical protein | |||||
| 193 | 222676–223716 (347) | Hypothetical protein | |||||
| 194 | 224007–224258 (84) | Hypothetical protein; hydrophobic; 12-mer repeats | |||||
| 195 | 224390–225718 (443) | Hypothetical protein; low sequence complexity | |||||
| 196 | 226126–226542 (139) | Hypothetical protein | |||||
| 197 | 226596–227135 (180) | Hypothetical protein; cysteine rich; low sequence complexity | |||||
| 198 | 227202–228812 (537) | Hypothetical protein; low sequence complexity | |||||
| 199 | 228872–229897 (342) | Hypothetical protein | |||||
| 200 | 229951–230268 (106) | Hypothetical protein | |||||
| 201 | 230293–230985 (231) | Hypothetical protein | |||||
| 202 | 231098–231802 (235) | Hypothetical protein | |||||
| 203 | 232049–233533 (495) | Hypothetical protein | |||||
| 204 | 233892–233491 (134) | 4 TM | Hypothetical protein; hydrophobic, consists mostly of hexapeptide repeats; TM prediction might be false positive | ||||
| 205 | 234526–235545 (340) | Hypothetical protein | |||||
| 206 | 235633–236631 (333) | Hypothetical protein | |||||
| 207 | 236777–238204 (476) | Inverted terminal repeat; identical to SGPV001 gene | |||||
| 208 | 238338–239324 (329) | Inverted terminal repeat; identical to SGPV002 gene | |||||
| 209 | 239360–240277 (306) | Inverted terminal repeat; identical to SGPV003 gene | |||||
| 210 | 240317–241267 (317) | Inverted terminal repeat; identical to SGPV004 gene |
In the first column, “SGPV” is omitted from the gene identifiers for brevity; in the last column “SGPV” is included; GI, GenInfo Identifier sequence identification number); aln_len, the length of pairwise protein alignment produced by BLASTP searches; SP, (predicted) signal peptide; TM, (predicted) transmembrane helix (C, M, and N denote the C-terminal, middle, and N-terminal location of the predicted transmembrane helix in the protein, respectively); the percent identity and alignment length are taken directly from BLASTP searches. IMV stands for intracellular mature virions; VARV stands for variola virus. The inferred origin of genes is indicated as follows: ANC, ancestral to NCLDV; POX, ancestral to poxviruses; CPOX, ancestral to chordopoxviruses; CACQ, convergent acquisition (with other NCLDVs); UAQ, unique acquisition. The transcription start element TAAAT is shown for those SGPV genes that have orthologs from other chordopoxviruses (the sequence TAAATG includes the translation start codon of the respective gene). Abbreviations for groups of viruses: Asco, Ascoviridae; Asf, Asfarviridae; Chor; Chordopoxvirinae; CrPV, crocodile poxvirus; Ent, Entomopoxvirinae; Iri, Iridoviridae; Mar, Marseilleviridae; MCV, molluscum contagiosum virus; Mimi, Mimiviridae; Pan, Pandoravirus; Phy, Phycodnaviridae; Pith, Pithovirus; Pox, poxviruses.
Protein lengths are in numbers of amino acids.
FIG 2Distribution of SGPV genes by tiers of inferred origin. The number of genes in each tier and the percentage of the total are indicated. NCLDV, genes inferred to have been present in the common ancestor of all NCLDVs; poxvirus, genes that originated in the common ancestor of the poxviruses; chordopoxvirus, genes that originated in the common ancestor of chordopoxviruses; TM/SP, transmembrane helix/signal peptide.
FIG 3Phylogenetic tree of poxviruses. The tree was constructed from a multiple-sequence alignment of 13 proteins that are conserved in all poxviruses and ASFV (NCVOG0022, major capsid protein; NCVOG0023, D5-like helicase-primase; NCVOG0031, unclassified DEAD/SNF2-like helicases; NCVOG0038, DNA polymerase elongation subunit family B; NCVOG0076, DNA or RNA helicases of superfamily II; NCVOG0249, packaging ATPase; NCVOG0261, poxvirus early transcription factor [VETF], large subunit; NCVOG0262, poxvirus late transcription factor VLTF-3-like; NCVOG0267, RNA helicase DExH-NPH-II; NCVOG0271, DNA-directed RNA polymerase subunit beta; NCVOG0274, DNA-directed RNA polymerase subunit alpha; NCVOG1117, mRNA capping enzyme; NCVOG1164, A1L transcription factor VLTF-2). The root position was forced between the two families. Numbers at internal nodes indicate bootstrap support (on a scale of from 0 to 1). Figure S1 in the supplemental material contains the alignments used to generate the tree.
FIG 4Reconstruction of the evolution of the gene repertoire of the NCLDVs. The numbers at internal branches (shown only for the ASFV-Poxviridae branch and for the root) indicate the maximum likelihood estimates of the number of genes mapped to the respective ancestral form. The numbers after the virus names indicate the number of annotated genes. The NCLDV families used as outgroups are shown by triangles. The NCLDV tree topology is from reference 25.
FIG 5Dot plot comparison of poxvirus gene orders. Each dot corresponds to a pair of orthologous genes. The horizontal axis shows the SGPV genes, and the vertical axis shows the GenInfo Identifier sequence identification numbers for genes of the respective viruses.
FIG 6Alignment of the genome architectures of SGPV and VACV. The alignment was generated using the Artemis tool and the table of gene orthology derived from the NCVOG assignments obtained in this work. The orthologous genes are connected by red lines, and the names of the respective vaccinia virus genes are indicated. nt, nucleotides.
FIG 7Synteny-based evolutionary tree of poxviruses. The root between chordopoxviruses and entomopoxviruses was forced. The tree was constructed using the neighbor-joining method, and the distances between the genome architectures of the respective viruses that were estimated as described previously (33) are shown in the table underneath the tree; a unit distance means that the fraction of orthologous gene pairs that belong to synteny blocks is equal to e−1. Amsmo, Amsacta moorei entomopoxvirus; Melsa, Melanoplus sanguinipes entomopoxvirus; Vacco, vaccinia virus; Deevi, deerpox virus; Psevi, pseudocowpox virus; Canvi, canarypox virus; Crovi, crocodilepox virus; Squvi, squirrelpox virus; Molco, molluscum contagiosum virus; Yabvi, Yaba-like disease virus.
FIG 8Phylogenetic tree of the viral B22R-like genes. The numbers on the left show bootstrap values as percentages. The bar shows the scale as the estimated number of amino acid substitutions per site. For the cyprinid herpesviruses, the GI numbers are indicated on the right. The three paralogs from SGPV are shown in red. The chordopoxvirus sequences are collapsed and shown as a triangle. Figure S2 in the supplemental material contains the alignments used for construction of the tree.
Conserved chordopoxvirus genes missing in SGPV
| Conserved gene | VACV gene | Known or predicted function | Essential | Comment |
|---|---|---|---|---|
| Genes conserved in chordopoxviruses and entomopoviruses | ||||
| 1178 | L5R | Membrane protein, fusion-entry complex subunit | Yes | |
| 1181 | A11R | Membrane-associated protein implicated in endoplasmic reticulum recruitment for virion morphogenesis | Yes | |
| 0040 | H1L | Dual-specificity (Ser/Thr and Tyr) protein phosphatase | Yes | Conserved in only two entomopoxviruses |
| Genes conserved only in chordopoxviruses | ||||
| 1185 | A20R | DNA polymerase processivity factor | Yes | |
| 1385 | I3L | Single-stranded DNA-binding protein essential for replication | Yes | |
| 1184 | G2R | Late transcription elongation factor | Yes | |
| 1172 | A12L | Virion core protein | Yes | |
| 1177 | F17R | DNA-binding virion core protein | Yes | |
| 1043 | G7L | Virion core protein required for immature virion formation | Yes | |
| 1398 | A19L | Virion core protein | Yes | |
| 0060 | G4L | Glutaredoxin involved in the pathway for cytoplasmic disulfide bond formation | Yes | |
| 1396 | A2.5L | Thioredoxin-like protein involved in the pathway for cytoplasmic disulfide bond formation | Yes | |
| 0012 | A33R | C-type lectin involved in extracellular virion morphogenesis | No | |
| 0268 | A25/A26L | A-type inclusion body-like protein | No | |
| 0255 | O1L | Poorly characterized protein, activator of the extracellular signal-regulated kinase pathway | No | |
| 1167 | F12L | Protein involved in intracellular enveloped virion maturation and cytoskeleton-dependent virion export | No | Inactivated derivative of DNA polymerase, possibly of bacteriophage origin |
| 1367 | G3L | Fusion-entry complex subunit | Yes | |
| 1376 | H7R | Protein involved in MV | Yes | |
| 1380 | A14L | Protein involved in MV membrane biogenesis | Yes | |
| 1411 | A17L | Protein involved in MV membrane biogenesis | Yes | |
| 1395 | L2R | Protein involved in MV membrane biogenesis | Yes | |
| 1366 | I5L | MV membrane protein | No | |
| 1383 | I2L | Membrane protein essential for virus entry | Yes | |
| 1391 | J1R | Protein involved in MV formation, assembly complex subunit | Yes | |
| 1416 | D3R | Protein involved in MV formation, assembly complex subunit | Yes | |
| 1412 | A30L | Protein involved in MV formation, assembly complex subunit | Yes | |
| 1392 | A9L | Protein involved in MV morphogenesis | Yes | |
| 0256 | H3L | MV membrane protein involved in cell attachment | No | |
| 1415 | A14.5L | MV membrane protein that enhances virulence | No |
NCVOG number.
Essentiality was determined for vaccinia virus.
MV, mature virion.